Truveta brand logo mark in teal on a black background, featuring stacked chevron shapes forming the Truveta symbol.
Close

Saving Lives with Data

Where yesterday's care becomes today's intelligence

Schedule a demo

Truveta Data

The most complete, real-time view of US healthcare

130M+

Patients and growing

Updated daily

Longitudinally linked:

Image
EHR
Image
Closed claims
Image
Devices
Image
Images
Image
SDOH
Image
Mother-child
Image
Multiomics
Image
Mortality
Explore Truveta Data

Truveta Intelligence

Answers in minutes, not months

Explore Truveta Intelligence
Image
Explore Truveta Intelligence

Truveta Evidence

Confidence through rigorous analytics and expertise

Image

Trusted research environment

Image
Immediately access Truveta Data and execute full research studies
Image
Dynamically refine cohorts with reusable, clinically precise definitions
Image
Produce audit-ready evidence aligned to regulatory standards
Explore Truveta Evidence

Truveta Evidence Services

Design rigorous studies alongside experts and deliver transparent, audit-ready evidence

Image
Extend capacity with trusted experts
Image
Accelerate timelines from protocol to submission
Image
Maximize value from real-world data
Image
De-risk high-impact regulatory and post-market studies
Learn more
350+

Publications

250+

Conference presentations

150K+

Citations

100+

Regulatory projects across US and global agencies

Learn more

Power every stage of care

Advance every decision with real-time intelligence and regulatory-grade evidence

Discovery

Discover new targets and train AI

Therapy adoption

Track patient access and industry trends in real time

Safety

Uncover safety signals faster from real-time data trusted by regulators

Outcomes research

Update evidence strategies in real-time across precise populations

Clinical trials

Simulate trials and identify eligible patients with unprecedented precision

Healthcare optimization

Benchmark care quality and enhance operations

Built with US health systems

Image
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Meet our members
Image
Pharmaceutical
Image
Medical device
Image
Healthcare
Image
Public health
Image
Academics

Ready for the entire healthcare ecosystem

Ready for the entire healthcare ecosystem

Image
Pharmaceutical
Image
Medical device
Image
Public health
Image
Healthcare
Image
Academics

Trusted by leading life science, public health, and healthcare organizations

Moderna
Boehringer Ingleheim
Providence
Boston Scientific
CommonSpirit
SK
Medcomp
Advocate
Northwell

Featured research

Research graphic highlighting increased measles immunity testing during periods of measles outbreak activity.

Measles outbreaks linked to increases in immunity testing among adults over 50

Truveta Research found measles titer testing among adults over 50 increased during the 2019 and 2025 outbreaks, with a sharp rise in Texas in 2025.

Truveta graphic promoting research on e-bike and e-scooter injuries, featuring the headline "E-bike and e-scooter injuries rising rapidly" with a subtitle highlighting increasing emergency department visits among children and adolescents over a background line chart of injury trends.

Emergency department visits related to e-bike and e-scooter injuries are rising rapidly among children and adolescents

Truveta Research finds e-bike and e-scooter injury ED visits rose 7.5-fold among children, with head and neck injuries most common.

Truveta graphic highlighting a JMCP study of real-world switching from Humira (adalimumab) to biosimilars in the United States, with a line chart showing increased biosimilar adoption after formulary changes.

Real-world study finds 1 in 7 patients returned to Humira after switching to an adalimumab biosimilar

A real-world study found 16% of patients switched back to Humira after starting an adalimumab biosimilar, highlighting transition challenges.

Research graphic highlighting rising progesterone-containing hormone replacement therapy use among women from 2018 to 2026.

Progesterone-containing hormone replacement therapy use is rising

Progesterone-containing hormone replacement therapy use is rising. Truveta Research found prescribing increased more than fourfold between 2018 and 2026.

Research graphic highlighting increased measles immunity testing during periods of measles outbreak activity.

Measles outbreaks linked to increases in immunity testing among adults over 50

Truveta graphic promoting research on e-bike and e-scooter injuries, featuring the headline "E-bike and e-scooter injuries rising rapidly" with a subtitle highlighting increasing emergency department visits among children and adolescents over a background line chart of injury trends.

Emergency department visits related to e-bike and e-scooter injuries are rising rapidly among children and adolescents

Truveta graphic highlighting a JMCP study of real-world switching from Humira (adalimumab) to biosimilars in the United States, with a line chart showing increased biosimilar adoption after formulary changes.

Real-world study finds 1 in 7 patients returned to Humira after switching to an adalimumab biosimilar

Research graphic highlighting rising progesterone-containing hormone replacement therapy use among women from 2018 to 2026.

Progesterone-containing hormone replacement therapy use is rising

Find more research

Featured in

Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Visit the newsroom

Follow us on LinkedIn to keep up with the latest from Truveta

Image
Follow us